New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...

Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed. A dose reduction of ...

Elevating cardiorespiratory fitness may considerably lower the incidence of prostate cancer, according to new research that was published in the British Journal of Sports Medicine. The Swedish School ...

The predictive value of HGPIN and ASAP for the subsequent diagnosis of prostate cancer in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: REDUCE was a randomized, ...

Charities described the reduction in sessions as 'transformative' as it allows doctors to cut waiting lists faster and saves ...

Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...